Skip to content
OpenCapital
Get started

Pfizer PFE Biopharma — Revenues:

Similar metrics at other companies

Labcorp Holdings logo
LHBiopharma Laboratory Services — Revenue
$780.6M+8.2%
Becton, Dickinson and Company logo
BDXBioPharma Systems — Revenue
$590M+2.6%
Guardant Health logo
GHBiopharma and data — Total Revenue
$52.98M+16.8%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — Product revenues, net
$2.99B+7.8%
STERIS logo
STELife Sciences: — Revenue
$145.8M+6.9%
Vertex Pharmaceuticals logo
VRTXProduct revenues, net — Product revenues, net
$2.99B+8.2%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×—
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's biopharma — revenues:.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's biopharma — revenues:?
Pfizer (PFE) reported biopharma — revenues: of $14.16B in Q1 2026.
How has Pfizer's biopharma — revenues: changed year-over-year?
Pfizer's biopharma — revenues: increased by 5.4% year-over-year, from $13.44B to $14.16B.
What is the long-term trend for Pfizer's biopharma — revenues:?
Over 4 years (2021 to 2025), Pfizer's biopharma — revenues: has grown at a -6.3% compound annual growth rate (CAGR), from $79.56B to $61.2B.
What does biopharma — revenues: mean?
The total gross income generated from the sale of pharmaceutical products, vaccines, and related services within the biopharma segment. It serves as the primary indicator of market demand and the commercial success of the segment's product portfolio.